摘要
慢性肾脏病（chronic kidney disease，CKD）是一种常见疾病，可进展至终末期肾脏病（ESRD），并引起心血管事件及其他系统损害。研究发现血管再生相关因子参与CKD的发生发展。血管生成素（angiopoietin，Ang）及其受体不仅参与生理性血管的形成，也参与慢性肾脏病的进展，调节这些因子对慢性肾脏病有治疗性作用。
出处
《国际泌尿系统杂志》
2013年第2期255-259,共5页
International Journal of Urology and Nephrology
基金
国家自然科学基金资助项目（NO.30800523）
湖北省科学自然基金（2010CDB07906）
参考文献37
-
1CoreshJ, Astor BC, Greene T , et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. AmJ Kidney Dis,2003 ,41: 1 -12.
-
2Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross - sectional survey. Lancet , 2012 , 379 (9818) :815 -822.
-
3Thurston G, RudgeJS, loffe E, et al. Angiopoietin - 1 protects the adult vasculature against plasma leakage. Nat Med, 2000,6: 460 -463.
-
4Suri C,Jones P F, Patan S, et al. Requisite role of angiopoietin - 1, a ligand for the TIE - 2 receptor, during embryonic angio?genesis. Cell, 1996,87(7) :1171 -1180.
-
5Maisonpierre PC, Suri C,Jones PF, et al. Angiopoietin - 2, a natural antagonist for Tie - 2 that disrupts in vivo angiogenesis. Science, 1997,277(5322) :55 -60.
-
6Witzenbicbler B, Maisonpierre PC,Jones P, et al. Chemotactic properties of angiopoietin - 1 and - 2, ligands for the endothelial - specific receptor tyrosine kinase Tie - 2.J Bioi Chern, 1998, 273: 18514 -18521.
-
7Yuan HT, Khankin EV, Karumanchi SA, et al. Angiopoietin 2 is a partial agonist! antagonist of Tie - 2 signaling in the endothelium. Mol Cell Biol,2009,29(8) :2011 -2022.
-
8Song SH, Kim KL, Lee KA, et al. Tiel regulates the Tie - 2 ago?nistic role of angiopoietin - 2 in human lymphatic endothelial cells. Biochem Biophys Res Commun,2012,419(2) :281 -286.
-
9Suri C, McClainJ, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin - 1. Science, 1998, 282 (5388) :468 -471.
-
10Thurston G, Suri C, Smith K, et al. Leakage - resistant blood vessels in mice transgenically overexpressing angiopoietin - 1. Science, 1999 ,286(5449) :2511 -2514.
同被引文献27
-
1Bronckaers A, Hilkens P, Martens W, et al. Mesenchymal stem/stro- mal ceils as a pharmacological and therapeutic approach to acceler- ate angiogenesis [ J ]. Pharmacol Ther,2014,143 (2) : 181 - 196.
-
2Eliopoulos N,Zhao J,Bouchentouf M,et al. Human mm'row -derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post - intraperitoneal injection [ J]. Am J Physiol Renal Physiol. 2010,299 (6) : F1288 - 1298.
-
3Yagi H ,Soto - Gutierrez A,Kitaqawa Y ,et al. Bone marrow mesen- chymal stromal cells attenuate organ injury induced by LPS and burn [ J ]. Cell Transplant,2010,19 (6) :823 - 830.
-
4Liu L, Yu Y, Hou Y, et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of se- vere burned rats[ J]. PLoS One ,2014,9 ( 2 ) :e88348.
-
5Rahbarghazi R, Nassiri SM, Ahmadi SH, et al. Dynamic induction of pro - angiogenic millieu after transplantation of marrow - derived mesenchymal stem cells in experimental myocardial infarction [ J ]. Int J Cardiol,2014,173 ( 3 ) :453 - 466.
-
6Plotkin MD, Goliqorsky MS. Mesenchymal cells from aduh kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin - producing fibroblasts [ J ]. AM J Physiol Renal Physio1,2006,291 (4) : F902 - 912.
-
7Xing L, Cui R, Pang L, et al. Mesenchymal stem cells, not condi- tioned medium, contribute to kidney repair after ischemia - reper- fusion injury[ J]. Stem Cell Res Ther,2014,5 (4) :101.
-
8Villanueva S, Carreno JE, Salazar L, et al. Human mesenchymal stem ceils derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure [ J ]. Clin Sci (Lond) ,2013,125 (4) : 199 - 210.
-
9Asanuma H, Meldrum DR, Meldrum KK. Therapeutic application of mesenchymal stem ceils to repair kidney injury [ J ]. J Urol, 2010,184( 1 ) :26 -33.
-
10Boomsma RA, Geenen DL. Mesenchymal stem ceils secrete multi- pie cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis[ J]. PLoS 0ne,2012,7(4) : e35685 - e35694.
-
1麦振华,姚华国,张媛莉.血管生成素-1、2在脓毒症和急性肺损伤/急性呼吸窘迫综合征发生及发展过程中的作用[J].广东医学院学报,2011,29(2):203-206. 被引量：3
-
2武建文,徐虹,赵晓晴,周晓燕,吴滢.阿霉素肾病大鼠肾组织中血管生成素样蛋白3基因表达[J].中华肾脏病杂志,2006,22(1):37-42. 被引量：12
-
3顾红卫,倪兆慧.内皮因子与肾脏疾病研究进展[J].国外医学（泌尿系统分册）,2005,25(4):517-521. 被引量：3
-
4余艳丽,夏中元,方海滨,周斌,雷少青.DHA调节人脑血管周细胞氧糖剥夺-复氧复糖时血管生成素表达的机制：与SSeCKS的关系[J].中华麻醉学杂志,2017,37(2):188-191. 被引量：1
-
5汤洁,刘世清,李皓桓,刘文俊,郑慧锋.Ang-1,Ang-2及其受体Tie2在增生期血管瘤中的表达[J].武汉大学学报（医学版）,2008,29(5):623-625. 被引量：3
-
6杨佩娣.老年重度颅脑损伤患者呼吸系统的护理[J].齐齐哈尔医学院学报,2003,24(5):534-534. 被引量：4
-
7伍秋霞,龚智峰,彭小梅,曾西,李家燕.血液灌流治疗慢性肾功能衰竭患者继发性甲状旁腺功能亢进的临床观察[J].临床荟萃,2008,23(9):646-647. 被引量：1
-
8刘倩雯,叶啟发,李晓璟.血管生成素及其受体在脑死亡供者肾损伤中的调节作用[J].中华器官移植杂志,2014,35(11):701-703.
-
9李孝生,刘址忠,黄文英,朱贤立,赵洪洋.尼米舒利对人胶质瘤SHG44细胞VEGF、Ang基因表达的影响(英文)[J].中国现代医学杂志,2005,15(20):3046-3049.
-
10庄薇,钟宁.VEGF、Ang-2在腹膜透析大鼠腹膜组织中的表达[J].继续医学教育,2013,27(10):50-51. 被引量：1
